Henry C Kitchener

1992–2025 年に発表

別表記
Henry C. Kitchener
93
論文数
25,227
被引用数
76
h 指数
93
i10 指数

被引用数

Henry C Kitchener の年別被引用数1993 年: 被引用 5 件1994 年: 被引用 3 件1995 年: 被引用 10 件1996 年: 被引用 8 件1997 年: 被引用 13 件1998 年: 被引用 14 件1999 年: 被引用 11 件2000 年: 被引用 15 件2001 年: 被引用 9 件2002 年: 被引用 8 件2003 年: 被引用 30 件2004 年: 被引用 39 件2005 年: 被引用 46 件2006 年: 被引用 39 件2007 年: 被引用 49 件2008 年: 被引用 108 件2009 年: 被引用 109 件2010 年: 被引用 116 件2011 年: 被引用 150 件2012 年: 被引用 183 件2013 年: 被引用 163 件2014 年: 被引用 180 件2015 年: 被引用 230 件2016 年: 被引用 197 件2017 年: 被引用 226 件2018 年: 被引用 223 件2019 年: 被引用 857 件2020 年: 被引用 929 件2021 年: 被引用 837 件2022 年: 被引用 675 件2023 年: 被引用 452 件2024 年: 被引用 718 件2025 年: 被引用 304 件2026 年: 被引用 8 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,730 件、この内訳の 17.8%中国: 引用元論文 1,187 件、この内訳の 12.2%イギリス: 引用元論文 919 件、この内訳の 9.4%イタリア: 引用元論文 473 件、この内訳の 4.9%カナダ: 引用元論文 398 件、この内訳の 4.1%オランダ: 引用元論文 384 件、この内訳の 3.9%ドイツ: 引用元論文 376 件、この内訳の 3.9%フランス: 引用元論文 359 件、この内訳の 3.7%オーストラリア: 引用元論文 318 件、この内訳の 3.3%スペイン: 引用元論文 271 件、この内訳の 2.8%ベルギー: 引用元論文 269 件、この内訳の 2.8%インド: 引用元論文 186 件、この内訳の 1.9%
0%17.8%その他 29.3%

分野

  • Medicine74.3%
  • Biochemistry, Genetics and Molecular Biology16.5%
  • Immunology and Microbiology4.3%
  • Computer Science1.5%
  • Engineering0.4%
  • Agricultural and Biological Sciences0.4%
  • その他2.6%

トピック

  • Cervical Cancer and HPV Research12.2%
  • Endometrial and Cervical Cancer Treatments8.8%
  • Ovarian cancer diagnosis and treatment6.7%
  • Reproductive tract infections research2.6%
  • Global Cancer Incidence and Screening2.4%
  • Hepatitis B Virus Studies2.3%
  • その他65%

共著者

全論文

検索で開く
  1. Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 837

  2. Ovarian cancer

    著者: , , , - The Lancet 2014 被引用: 1,873

  3. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

    著者: , , , , , , , , , , , , - The Lancet 2013 被引用: 1,802

  4. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

    著者: , , , , , , , , , , , , , , , , - The Lancet 2015 被引用: 1,395

  5. Cervical cancer: A global health crisis

    著者: , , , , , , , , , , - Cancer 2017 被引用: 1,195

  6. Human papillomavirus and cervical cancer

    著者: , , , - The Lancet 2013 被引用: 1,170

  7. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

    著者: , , , , , , , , , , , , , , - Modern Pathology 2015 被引用: 490

  8. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mary McCormack, Karen Whitmarsh, R. Allerton, D. Gregory, Paul Symonds, Peter Hoskin, Madhavi Adusumalli, Anjana Anand, Robert Wade, Alexandra Stewart, W. Chris Taylor, LCHW Lutgens, Harry Hollema, E. Pras, An Snyers, Henrike Westerveld, JJ Jobsen, Annerie Slot, JM Mens, TC Stam, Baukelien van Triest, E. van der Steen-Banasik, K. Winter, MA Quinn, Ilka Kolodziej, Jan Pyman, Carol Johnson, Anne Capp, Roldano Fossati, Alessandro Colombo, Silvestro Carinelli, Annamaria Ferrero, Grazia Artioli, Catherine Davidson, C. Meg McLachlin, Prafull Ghatage, PVC Rittenberg, Luís Souhami, Gillian Thomas, Pierre Duvillard, D Berton-Rigaud, N. Tubiana-Mathieu - The Lancet Oncology 2019 被引用: 456

  9. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mary McCormack, Karen Whitmarsh, R. Allerton, D. Gregory, Paul Symonds, Peter Hoskin, Madhavi Adusumalli, Anjana Anand, Robert Wade, Alexandra Stewart, W. Chris Taylor, Roy F.P.M. Kruitwagen, Harry Hollema, E. Pras, An Snyers, Lukas L Stalpers, Jan J. Jobsen, Annerie Slot, Jan-Willem M. Mens, Tanja C. Stam, Baukelien van Triest, Elzbieta M. Van der Steen - Banasik, Karin A.J. De Winter, Michael Quinn, Ilka Kolodziej, Jan Pyman, Carol Johnson, Anne Capp, Roldano Fossati, Sergio Gribaudo, Andrea Alberto Lissoni, Annamaria Ferrero, Grazia Artioli, Cathy N. Davidson, C. Meg McLachlin, Prafull Ghatage, Paula V.C. Rittenberg, Luís Souhami, Gillian Thomas, Pierre Duvillard, Dominique Berton-Rigaud, N. Tubiana-Mathieu - The Lancet Oncology 2018 被引用: 623

  10. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2009 被引用: 1,655

  11. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2011 被引用: 703

  12. The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark J. Arends, James M. Bolton, Tjalling Bosse, John Burn, Emma J. Crosbie, Emma J. Crosbie, David N. Church, Joanna M. Cornes, Robin Crawford, K. J. Donnelly, Diana Eccles, Richard J. Edmondson, D. Gareth Evans, Ian M. Frayling, Sadaf Ghaem-Maghami, Paula Gollop, Selina Goodman, Heather Hampel, Shirley Hodgson, Noah D. Kauff, Henry C. Kitchener, Sarah J. Kitson, Fiona Lalloo, Anne Lowry, Ranjit Manchanda, Raymond F.T. McMahon, Rhona J. McVey, Usha Menon, Tracie Miles, Gabriela Möslein, Pål Møller, Kevin Monahan, Adam N. Rosenthal, Neil Ryan, Peter Sasieni, Mourad W. Seif, Pauline Skarrott, Naveena Singh, Tristan Snowsill, R. Steele, Astrid Stormoken, Helen F. Stringfellow, Marc Tischkowitz, Andrew J. Wallace, Luciya Whyte, Nafisa Wilkinson, Godfrey Wilson, Jo Wilson, Nick Wood, D. Gareth Evans - Genetics in Medicine 2019 被引用: 235

  13. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roberto Angioli, Rahul Nath, K. Chin, Charles Redman, Robert Lotocki, Adeola Olaitan, Berit Jul Mosgaard, Gordon Rustin, Thomas Ind, Mojca Persic, Martin Hogg, Jacobus van der Velden, Jonathan A. Ledermann, Peter Sykes Peter Sykes, Krishnawam Madhavan, Päivi Kannisto, V Hird, Anthony C. Evans, R. Sandvei R., Philippe Gauthier, Derek Cruickshank, P.B. Ottevanger, Sheila E. Pearson, Henry C Kitchener, Marcia Hall, Paul Bessette, S. Pecorelli, Eva Gerdin, Tito Lopes, Andrew Fish, Clare Barlow, Koen Van Eygen, Anne Floquet, Bengt Tholander, Nurdan Gül, Robert Gornall, David Luesley, P. H. Kirwan, Paul Symonds, Richard Henry, David Poole, Ian McNeish, M A Hocking, Al Sammaraie, P Speiser, Éric Leblanc, J.A. Green, C Fernández Oliveira, Robert Grimshaw, Paolo Zola, David E. Parkin, David Luesley, Martin Lamb, Anne Hong, Alan Gillespie, Abdel Hamid, Ahmed Ahmed, Marie Plante, B. De Valk, A Nordin, Andrew R. Clamp, D Díaz Pérez, Graham Dark, Michelle Ferguson, Carol MacGregor, G. Skailes, Rachel Jones, Alan Gillespie, G. Cawdell, Simon Leeson ほか 43 名 - The Lancet Oncology 2018 被引用: 306

  14. Primary cervical screening with high risk human papillomavirus testing: observational study

    著者: , , , , , , , , , , , , , , , , , , , , , - BMJ 2019 被引用: 175

  15. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2011 被引用: 507

  16. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2007 被引用: 1,315

  17. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dominique Descamps, P.V. Suryakiran, Naveen Karkada, Brecht Geeraerts, Gary Dubin, Frank Struyf - The Lancet Infectious Diseases 2016 被引用: 192

  18. Chapter 7: Achievements and limitations of cervical cytology screening

    著者: , , - Vaccine 2006 被引用: 268

  19. The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk

    著者: , , , , , , , , , , , , , , - International Journal of Cancer 2018 被引用: 127

  20. 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer

    著者: , , , , , , , , - International Journal of Gynecological Cancer 2011 被引用: 425

  21. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT

    著者: , , , - Health Technology Assessment 2019 被引用: 89

  22. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2014 被引用: 182

  23. The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot

    著者: , , , , , - British Journal of Cancer 2022 被引用: 30

  24. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial

    著者: , , , , , , , , , , , , , , , - The Lancet Oncology 2009 被引用: 393